Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA

BACKGROUND: Immune-related adverse events (irAEs) are a serious side effect of immune checkpoint inhibitor (ICI) therapy for patients with advanced cancer. Currently, predisposing risk factors are undefined but understanding which patients are at increased risk for irAEs severe enough to require hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalinich, Mark, Murphy, William, Wongvibulsin, Shannon, Pahalyants, Vartan, Yu, Kun-Hsing, Lu, Chenyue, Wang, Feicheng, Zubiri, Leyre, Naranbhai, Vivek, Gusev, Alexander, Kwatra, Shawn G, Reynolds, Kerry L, Semenov, Yevgeniy R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016099/
https://www.ncbi.nlm.nih.gov/pubmed/33789879
http://dx.doi.org/10.1136/jitc-2020-001935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016099/
https://www.ncbi.nlm.nih.gov/pubmed/33789879
http://dx.doi.org/10.1136/jitc-2020-001935

Ejemplares similares